Octaplas™

BIOLOGICAL2 trials

Sponsors

Octapharma

Conditions

Adverse Effects in the Therapeutic Use of Plasma SubstitutesCoagulopathyEndstage Liver Disease

Phase 4

Octaplas Pediatric Plasma Exchange Trial

CompletedNCT01938378

OctapharmaAdverse Effects in the Therapeutic Use of Plasma Substitutes

Start: 2015-04-30End: 2019-01-27Updated: 2020-03-24

Unknown Phase

Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation

TerminatedNCT02037373

OctapharmaCoagulopathy, Endstage Liver Disease

Start: 2015-08-31End: 2018-02-28Updated: 2018-03-07